MFS
RGNX icon

Mirabella Financial Services’s Regenxbio RGNX Stock Holding History

Mirabella Financial Services’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-25,983
Closed -$5.46M – 628
2023
Q1 		$5.46M Buy
+25,983
New +$575K 0.83% 38

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return

Mirabella Financial Services's RGNX Position: Q2 2023 in Review

Mirabella Financial Services sold out of Regenxbio (RGNX) in Q2 2023, closing a stake of 25,983 shares — an estimated $5.46M sold.

Mirabella Financial Services first reported a position in RGNX in Q1 2023 and held it in 1 quarter. The position peaked at $5.46M in Q1 2023. 167 funds tracked by Wall St. Rank hold RGNX as of Q2 2023.

  • Mirabella Financial Services reported no remaining Regenxbio position as of Q2 2023 after selling out during the quarter.
  • Mirabella Financial Services sold 25,983 Regenxbio shares in Q2 2023, an estimated $5.46M.
  • Mirabella Financial Services first reported a position in Regenxbio in Q1 2023 and held it in 1 quarter.
  • Mirabella Financial Services's Regenxbio position peaked at $5.46M in Q1 2023.
  • 167 funds tracked by Wall St. Rank held Regenxbio as of Q2 2023.

Based on Mirabella Financial Services's 13F filing for Q2 2023, filed 7 Aug 2023.